Zerrin Onadim

1.2k total citations
33 papers, 897 citations indexed

About

Zerrin Onadim is a scholar working on Ophthalmology, Oncology and Molecular Biology. According to data from OpenAlex, Zerrin Onadim has authored 33 papers receiving a total of 897 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Ophthalmology, 23 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Zerrin Onadim's work include Ocular Oncology and Treatments (31 papers), Cancer-related Molecular Pathways (22 papers) and Head and Neck Surgical Oncology (7 papers). Zerrin Onadim is often cited by papers focused on Ocular Oncology and Treatments (31 papers), Cancer-related Molecular Pathways (22 papers) and Head and Neck Surgical Oncology (7 papers). Zerrin Onadim collaborates with scholars based in United Kingdom, India and Australia. Zerrin Onadim's co-authors include John K. Cowell, Annette Hogg, Paul N. Baird, M. Ashwin Reddy, Mandeep S. Sagoo, Elizabeth Price, Catriona Duncan, J L Hungerford, Ido Didi Fabian and Tanzina Chowdhury and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Oncogene and British Journal of Cancer.

In The Last Decade

Zerrin Onadim

31 papers receiving 873 citations

Peers

Zerrin Onadim

OPHTH

ONCOL

MB

CR

RNMI

Wilma G. M. Kroes Netherlands

Jerry A. Shields United States

Emma Kujala Finland

Irsan Kooi Netherlands

Jennifer Richards‐Yutz United States

W Höpping Germany

Sameh E. Soliman Egypt

Daniela Süßkind Germany

Maria Antonietta Blasi Italy

Willem Maat Netherlands

Wilma G. M. Kroes Netherlands

Zerrin Onadim

515 ×0.8

OPHTH

366 ×0.7

ONCOL

395 ×1.0

MB

136 ×1.0

CR

116 ×1.1

RNMI

Citations per year, relative to Zerrin Onadim Zerrin Onadim (= 1×) peers Wilma G. M. Kroes

Countries citing papers authored by Zerrin Onadim

Since Specialization

Citations

This map shows the geographic impact of Zerrin Onadim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zerrin Onadim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zerrin Onadim more than expected).

Fields of papers citing papers by Zerrin Onadim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zerrin Onadim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zerrin Onadim. The network helps show where Zerrin Onadim may publish in the future.

Co-authorship network of co-authors of Zerrin Onadim

This figure shows the co-authorship network connecting the top 25 collaborators of Zerrin Onadim. A scholar is included among the top collaborators of Zerrin Onadim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zerrin Onadim. Zerrin Onadim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Price, Elizabeth, Mandeep S. Sagoo, M. Ashwin Reddy, & Zerrin Onadim. (2023). An overview of RB1 transcript alterations detected during retinoblastoma genetic screening. Ophthalmic Genetics. 45(3). 235–245.

2.

Reddy, M. Ashwin, et al.. (2020). Prognostic Information for Known Genetic Carriers of RB1 Pathogenic Variants (Germline and Mosaic). Ophthalmology Retina. 5(4). 381–387. 6 indexed citations

3.

Fabian, Ido Didi, Noa Kapelushnik, Zerrin Onadim, et al.. (2020). Number, frequency and time interval of examinations under anesthesia in bilateral retinoblastoma. Graefe s Archive for Clinical and Experimental Ophthalmology. 258(4). 879–886. 4 indexed citations

4.

Fabian, Ido Didi, Noa Kapelushnik, Zerrin Onadim, et al.. (2019). Examinations under anaesthesia as a measure of disease burden in unilateral retinoblastoma: the London experience. British Journal of Ophthalmology. 104(1). 17–22. 6 indexed citations

5.

Fabian, Ido Didi, Zerrin Onadim, Esin Kotiloğlu Karaa, et al.. (2018). The management of retinoblastoma. Oncogene. 37(12). 1551–1560. 180 indexed citations

6.

Fabian, Ido Didi, Andrew W. Stacey, Zerrin Onadim, et al.. (2018). Strabismus in retinoblastoma survivors with long-term follow-up. Journal of American Association for Pediatric Ophthalmology and Strabismus. 22(4). 276.e1–276.e7. 6 indexed citations

7.

Price, Elizabeth, Roopal Patel, Esin Kotiloğlu Karaa, et al.. (2018). Detection and reporting of RB1 promoter hypermethylation in diagnostic screening. Ophthalmic Genetics. 39(4). 526–531. 13 indexed citations

8.

Fabian, Ido Didi, Andrew W. Stacey, Kenneth P. Johnson, et al.. (2016). Primary intravenous chemotherapy for group D retinoblastoma: a 13-year retrospective analysis. British Journal of Ophthalmology. 101(1). 82–88. 30 indexed citations

9.

MacCarthy, Angela, J M Birch, G J Draper, et al.. (2008). Retinoblastoma in Great Britain 1963-2002. British Journal of Ophthalmology. 93(1). 33–37. 66 indexed citations

10.

Mao, Xin, Zerrin Onadim, Elizabeth Price, et al.. (2003). Genomic Alterations in Blastic Natural Killer/Extranodal Natural Killer-Like T Cell Lymphoma with Cutaneous Involvement. Journal of Investigative Dermatology. 121(3). 618–627. 27 indexed citations

11.

Nicolantonio, Federica Di, et al.. (2003). The Chemosensitivity Profile of Retinoblastoma. Recent results in cancer research. 161. 73–80. 9 indexed citations

12.

Lillington, Debra M., Judith Kingston, Pietro G. Coen, et al.. (2002). Comparative genomic hybridization of 49 primary retinoblastoma tumors identifies chromosomal regions associated with histopathology, progression, and patient outcome. Genes Chromosomes and Cancer. 36(2). 121–128. 62 indexed citations

13.

Lillington, Debra M., Lindsey K. Goff, J E Kingston, et al.. (2002). High level amplification of N-MYC is not associated with adverse histology or outcome in primary retinoblastoma tumours. British Journal of Cancer. 87(7). 779–782. 27 indexed citations

14.

Sütterlin, Marc, Patrick Sleiman, Zerrin Onadim, & Joy Delhanty. (1999). Single cell detection of inherited retinoblastoma predisposition. Prenatal Diagnosis. 19(13). 1231–1236. 14 indexed citations

15.

Sütterlin, Marc, Patrick Sleiman, Zerrin Onadim, & Joy Delhanty. (1999). Single cell detection of inherited retinoblastoma predisposition. Prenatal Diagnosis. 19(13). 1231–1236. 1 indexed citations

16.

Onadim, Zerrin, et al.. (1997). The RB1 gene mutation in a child with ectopic intracranial retinoblastoma. British Journal of Cancer. 76(11). 1405–1409. 8 indexed citations

17.

Hogg, Annette, Britta Bia, Zerrin Onadim, & John K. Cowell. (1993). Molecular mechanisms of oncogenic mutations in tumors from patients with bilateral and unilateral retinoblastoma.. Proceedings of the National Academy of Sciences. 90(15). 7351–7355. 73 indexed citations

18.

Onadim, Zerrin, Annette Hogg, & John K. Cowell. (1993). Mechanisms of oncogenesis in patients with familial retinoblastoma. British Journal of Cancer. 68(5). 958–964. 9 indexed citations

19.

Onadim, Zerrin, J L Hungerford, & John K. Cowell. (1992). Follow-up of retinoblastoma patients having prenatal and perinatal predictions for mutant gene carrier status using intragenic polymorphic probes from the RB1 gene. British Journal of Cancer. 65(5). 711–716. 27 indexed citations

20.

Cowell, John K. & Zerrin Onadim. (1990). Carrier detection and prenatal screening of the retinoblastoma gene. The Journal of Pathology. 161(1). 3–5. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact